ArticleScientific reports2024

Cytokine signature in convalescent SARS-CoV-2 patients with inflammatory bowel disease receiving vedolizumab.

Simone Dallari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.